Streamline Health Solutions, In with ticker code (STRM) have now 2 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 3 and 2 and has a mean target at 2.5. Now with the previous closing price of 1.63 this indicates there is a potential upside of 53.4%. The 50 day MA is 1.61 and the 200 moving average now moves to 1.43. The company has a market capitalisation of $52m. Find out more information at: http://www.streamlinehealth.net
The potential market cap would be $79m based on the market concensus.
Streamline Health Solutions provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers health information management; coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, such as computer-assisted coding, CDI, and abstracting and physician query; and eValuator, a cloud-based pre- and post-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration, training, electronic image conversion, audit, and database monitoring services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions was founded in 1989 and is headquartered in Alpharetta, Georgia.
